KCNQ1 rs17400619: What Your Genotype Means
The rs17400619 variant is a genetic marker located within the KCNQ1 gene. It has been studied for its potential association with susceptibility to type 2 diabetes and its role in the regulation of insulin secretion from pancreatic beta-cells.
What each genotype means
Average risk profile
This is the most common genotype observed in many populations. Research suggests this genotype does not confer the specific increased risk for type 2 diabetes or altered insulin secretion regulation associated with the minor allele of this variant.
Carried by the majority of individuals in many global populations, though frequencies vary by ancestry.
Possible metabolic risk association
You carry one copy of the variant allele. Some studies have investigated whether this variant influences susceptibility to type 2 diabetes and the regulation of beta-cell insulin secretion; however, the evidence remains limited and inconsistent across different ancestries. This marker should not be used for medical diagnosis, and you should discuss any metabolic health concerns or diabetes risk factors with your clinician.
This genotype is more common in East Asian populations (where the risk allele frequency is approximately 0.30–0.45) than in populations of European ancestry.
Possible metabolic risk association
You carry two copies of the variant allele. Research has explored associations between this variant and type 2 diabetes susceptibility and insulin secretion, but current scientific evidence is limited and remains inconclusive regarding the strength of this link. Please note that genetic markers only provide a partial picture of metabolic health; discuss your overall risk profile and any preventive measures with your healthcare provider.
This genotype is less common than the GG or GA genotypes, with its prevalence tied to the frequency of the A allele in your specific ancestral background.
Understanding the rs17400619 Variant
The rs17400619 variant is a single nucleotide polymorphism (SNP) situated within the KCNQ1 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. This specific variant is located in a region of the genome that has been the subject of extensive investigation through genome-wide association studies (GWAS). These studies aim to identify links between specific genetic variations and complex health traits. Because rs17400619 is located in a non-coding region of the gene, researchers often investigate whether it influences how the KCNQ1 gene is regulated or expressed rather than changing the structure of the protein itself. Understanding the location of this SNP helps scientists map the complex genetic architecture that may contribute to metabolic health.
The Role of the KCNQ1 Gene
The KCNQ1 gene provides instructions for making a protein that functions as a voltage-gated potassium channel. These channels are essential for the proper flow of potassium ions across cell membranes, which is a critical process for maintaining the electrical activity of cells. While KCNQ1 is widely recognized for its role in the heart, where it helps regulate the rhythm of the heartbeat, it is also expressed in the pancreas. In pancreatic beta-cells, these potassium channels play a vital role in the signaling pathway that triggers the release of insulin. When the function of these channels is altered, it may affect the timing or amount of insulin secreted in response to blood glucose levels. Consequently, variations in this gene are of significant interest to researchers studying the mechanisms behind glucose metabolism and insulin regulation.
Research and Evidence Strength
Research into rs17400619 and its link to type 2 diabetes has yielded mixed results, leading to a classification of limited evidence strength. While several large-scale studies have identified the KCNQ1 locus as a susceptibility region for type 2 diabetes, the specific contribution of individual variants like rs17400619 can vary significantly between different ethnic groups. Some studies suggest that certain alleles at this locus are associated with impaired insulin secretion, which is a hallmark of type 2 diabetes development. However, because type 2 diabetes is a complex, polygenic condition influenced by both environmental factors and many different genes, it is difficult to isolate the effect of a single SNP. Current scientific consensus emphasizes that while this variant is part of a known susceptibility locus, it is not a diagnostic tool and does not determine an individual's health outcome on its own.
Population Frequency and Interpretation
The frequency of the rs17400619 variant differs across global populations, which is a common observation in genetic research. Data indicates that the risk allele frequency is approximately 0.30 to 0.45 in East Asian populations, while it is generally lower in populations of European ancestry. These differences highlight the importance of considering ancestral background when interpreting genetic data. It is important to note that having a specific genotype does not mean an individual will develop a condition. Genetic associations are statistical observations made across large groups of people, not individual predictions. Readers should view this information as a piece of a much larger puzzle that includes lifestyle, diet, and other genetic factors. If you have concerns about your metabolic health or diabetes risk, it is essential to consult with a healthcare professional who can provide personalized medical advice based on your clinical history.
How common is this variant?
The risk allele frequency for rs17400619 is approximately 0.30-0.45 in East Asian populations and is observed at lower frequencies in populations of European ancestry.
Frequently asked questions
Does having the rs17400619 variant mean I have diabetes?
No. This variant is a statistical marker associated with a susceptibility locus, not a diagnostic test for diabetes. Many factors, including lifestyle and other genetic variants, determine your actual health status.
Can I use this information to change my diet?
Genetic information should not be used to make medical or dietary changes without professional guidance. Always consult with a registered dietitian or your doctor before making significant changes to your health regimen.
Why do different studies show different results for this SNP?
Genetic associations can vary due to differences in study design, sample sizes, and the ancestral backgrounds of the participants. Complex traits like diabetes are influenced by many genes, making it difficult to isolate the effect of one single variant.
Where can I find more information about my specific health risks?
The best source for understanding your personal health risks is a qualified healthcare provider. They can interpret your medical history, family history, and clinical test results to provide accurate guidance.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17400619?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in KCNQ1
A rare variant in the KCNQ1 gene associated with Long QT syndrome.
Pathogenic missense variant associated with Long QT syndrome type 1.
This variant is associated with Long QT syndrome 1, a condition affecting the heart's electrical activity.
Pathogenic variant associated with Long QT Syndrome type 1 (Romano-Ward syndrome).
Intronic variant in KCNQ1 associated with type 2 diabetes susceptibility and fasting glucose levels.
Truncating variant p.Arg518Ter in KCNQ1 associated with Long QT Syndrome type 1.